AMT-130

Uniqure’s accelerated approval hopes take a hit
EP Vantage
Thu, 06/22/23 - 10:07 am
uniQure
Huntington's disease
gene therapy
AMT-130
UniQure revs up engines again for Huntington's gene therapy after trial hospitalizations
Fierce Biotech
Wed, 11/2/22 - 10:49 pm
uniQure
Huntington's disease
gene therapy
AMT-130
uniQure pauses part of Huntington's trial after 3 patients hospitalized—1 of whom hasn’t fully recovered
Fierce Biotech
Mon, 08/8/22 - 11:33 pm
uniQure
clinical trials
Huntington's disease
AMT-130
uniQure shares spike as investors see bright spot in 12-month Huntington's gene therapy data
Fierce Biotech
Thu, 06/23/22 - 07:51 pm
uniQure
Huntington's disease
gene therapy
AMT-130
UniQure moves Huntington's gene therapy to next phase of key trial
BioPharma Dive
Thu, 05/27/21 - 11:54 pm
uniQure
Huntington's disease
clinical trials
gene therapy
AMT-130
UniQure gets out the gate first in race for Huntington's gene therapy
BioPharma Dive
Sat, 06/20/20 - 09:41 pm
uniQure
clinical trials
Huntington's disease
AMT-130
UniQure presses go on Huntington’s gene therapy trial
Pharmaforum
Mon, 10/28/19 - 10:41 am
uniQure
Huntington's disease
gene therapy
AMT-130
clinical trials
UniQure snags patents on Huntington's gene therapy as it preps for the clinic
Biopharma Dive
Wed, 05/22/19 - 09:06 pm
uniQure
gene therapy
Huntington's disease
clinical trials
AMT-130